Transaction overview

Fusion Capital Partners completed its acquisition of AQUALIS on April 28, 2026, marking the private equity firm's entry into the environmental resources management sector. The deal value was not disclosed, but it is known that Fusion acquired a 100% stake in AQUALIS, which is headquartered in Morrisville, North Carolina. Founded in 2001, AQUALIS provides sustainable water compliance and management services to multi-state organizations and single-site clients for stormwater, wastewater, and potable water quality testing and management needs.

Deal structure and financing

Details on the equity and debt split were not provided by either party involved in the transaction. However, it is noted that Harris Williams acted as a buy-side advisor alongside Baird and Stifel. Additionally, Harris Williams was also a sell-side advisor to AQUALIS along with DFW Capital Partners, which had previously owned the company before its sale to Fusion Capital Partners. The deal does not disclose any retained stake by the seller or lock-up terms for key management at AQUALIS.

Strategic context

The acquisition of AQUALIS is seen as a strategic move for Fusion Capital Partners to bolster its presence in the growing environmental resources management sector. The firm's focus on water management aligns with AQUALIS’s expertise and market leadership, particularly given the fragmented nature of the industry and increasing regulatory demands around water compliance. For DFW Capital Partners, the sale reflects their successful investment strategy in founder-led companies that provide outsourced business services within regulated markets.

Regulatory path

No specific information was provided regarding regulatory scrutiny or approvals for this transaction. Given AQUALIS's national scope and service offerings across multiple states, it is likely that U.S. antitrust regulators such as the Federal Trade Commission (FTC) and Department of Justice (DOJ) would have been involved in reviewing the deal to ensure compliance with merger guidelines. However, no remedies were reported or publicly announced by either party.